Novo Nordisk Tops Quarterly Views, Tempers Full-Year Outlook

In This Article:

Novo Nordisk's (NVO) first-quarter results topped Wall Street's projections, while the Danish drugma

Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.